摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2-Deoxy-β-D-erythro-pentofuranosyl)pyrimido[1,2-α]purin-10(3)-one-5'-monophosphate | 213131-44-3

中文名称
——
中文别名
——
英文名称
3-(2-Deoxy-β-D-erythro-pentofuranosyl)pyrimido[1,2-α]purin-10(3)-one-5'-monophosphate
英文别名
3-(2-deoxy-β-D-erythro-pentafuranosyl)pyrimido[1,2-a]purin-10(3H)-one 5'-monophosphate;3-(2'-deoxy-β-D-erythro-pentofuranosyl)pyrimido[1,2-a]purin-10(3H)-one 5'-phosphate;3-(2-Deoxy-beta-D-ribofuranosyl)-pyrido[5,6-A]-purine-10-one-5'-monophosphate;[(2R,3S,5R)-3-hydroxy-5-(10-oxopyrimido[1,2-a]purin-3-yl)oxolan-2-yl]methyl dihydrogen phosphate
3-(2-Deoxy-β-D-erythro-pentofuranosyl)pyrimido[1,2-α]purin-10(3)-one-5'-monophosphate化学式
CAS
213131-44-3
化学式
C13H14N5O7P
mdl
——
分子量
383.257
InChiKey
VHESJINRMVWRRK-DJLDLDEBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.9
  • 重原子数:
    26
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    159
  • 氢给体数:
    3
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(2-Deoxy-β-D-erythro-pentofuranosyl)pyrimido[1,2-α]purin-10(3)-one-5'-monophosphate 在 phosphate buffer 作用下, 生成 N2-(3-oxoprop-1-enyl)deoxyguanosine 5'-phosphate sodium salt
    参考文献:
    名称:
    Kinetic and Thermodynamic Analysis of the Hydrolytic Ring-Opening of the Malondialdehyde−Deoxyguanosine Adduct, 3-(2‘-Deoxy-β-d-erythro-pentofuranosyl)- pyrimido[1,2-α]purin-10(3H)-one
    摘要:
    3-(2'- Deoxy-beta-D-erythro-pentofuranosyl) pyrimido[1,2-alpha]purin-10(3H)-one (M(1)dG) is the major reaction product of deoxyguanosine with malondialdehyde or base propenals. M(1)dG undergoes hydrolytic ring-opening to N-2-oxopropenyl-deoxyguanosine (N(2)OPdG) under basic conditions. We report that ring-opening of M(1)dG as a nucleoside or in oligonucleotides is a reversible second-order reaction with hydroxide ion. NMR and UV analysis revealed N(2)OPdG(-) to be the only product of M(1)dG ring-opening in basic solution. The rate constant for reaction of M1dG with hydroxide is 3.8 M-1 s(-1), and the equilibrium constant is calculated to be 2.1 +/- 0.3 x 10(4) M-1 at 25 degreesC. Equilibrium constants determined by spectroscopic analysis of the reaction end-point or by thermodynamic analysis of rate constants determined over a range of temperatures yielded a value 2.5 +/- 0.2 x 10(4) M-1. Kinetic analysis of ring-opening of M1dG in oligonucleotides indicated the rate constant for ring-opening is decreased 10-fold compared to that in the nucleoside. Flanking purines or pyrimidines did not significantly alter the rate constants for ring-opening, but purines flanking M1dG enhanced the rate constant for the reverse reaction. A mechanism is proposed for ring-opening of M(1)dG under basic conditions and a role is proposed for duplex DNA in accelerating the rate of ring-opening of M(1)dG at neutral pH.
    DOI:
    10.1021/ja040009r
  • 作为产物:
    描述:
    N2-(3-oxoprop-1-enyl)deoxyguanosine 5'-phosphate sodium salt 在 phosphate buffer 作用下, 生成 3-(2-Deoxy-β-D-erythro-pentofuranosyl)pyrimido[1,2-α]purin-10(3)-one-5'-monophosphate
    参考文献:
    名称:
    Kinetic and Thermodynamic Analysis of the Hydrolytic Ring-Opening of the Malondialdehyde−Deoxyguanosine Adduct, 3-(2‘-Deoxy-β-d-erythro-pentofuranosyl)- pyrimido[1,2-α]purin-10(3H)-one
    摘要:
    3-(2'- Deoxy-beta-D-erythro-pentofuranosyl) pyrimido[1,2-alpha]purin-10(3H)-one (M(1)dG) is the major reaction product of deoxyguanosine with malondialdehyde or base propenals. M(1)dG undergoes hydrolytic ring-opening to N-2-oxopropenyl-deoxyguanosine (N(2)OPdG) under basic conditions. We report that ring-opening of M(1)dG as a nucleoside or in oligonucleotides is a reversible second-order reaction with hydroxide ion. NMR and UV analysis revealed N(2)OPdG(-) to be the only product of M(1)dG ring-opening in basic solution. The rate constant for reaction of M1dG with hydroxide is 3.8 M-1 s(-1), and the equilibrium constant is calculated to be 2.1 +/- 0.3 x 10(4) M-1 at 25 degreesC. Equilibrium constants determined by spectroscopic analysis of the reaction end-point or by thermodynamic analysis of rate constants determined over a range of temperatures yielded a value 2.5 +/- 0.2 x 10(4) M-1. Kinetic analysis of ring-opening of M1dG in oligonucleotides indicated the rate constant for ring-opening is decreased 10-fold compared to that in the nucleoside. Flanking purines or pyrimidines did not significantly alter the rate constants for ring-opening, but purines flanking M1dG enhanced the rate constant for the reverse reaction. A mechanism is proposed for ring-opening of M(1)dG under basic conditions and a role is proposed for duplex DNA in accelerating the rate of ring-opening of M(1)dG at neutral pH.
    DOI:
    10.1021/ja040009r
点击查看最新优质反应信息

文献信息

  • Development of Monoclonal Antibodies to the Malondialdehyde−Deoxyguanosine Adduct, Pyrimidopurinone<sup>1</sup>
    作者:Cynthia L. Sevilla、Norma H. Mahle、Naomi Eliezer、Adam Uzieblo、Shawn M. O'Hara、Munetaka Nokubo、Ryan Miller、Carol A. Rouzer、Lawrence J. Marnett
    DOI:10.1021/tx960120d
    日期:1997.2.1
    Malondialdehyde (MDA), an endogenous product of lipid peroxidation and prostaglandin biosynthesis, is mutagenic in bacterial and mammalian cells and carcinogenic in rats. In order to determine whether MDA-modified bases are formed in nucleic acids in vivo, sensitive immunoassays to detect MDA-DNA and MDA-RNA adducts are being developed in our laboratory. Murine monoclonal antibodies reactive with the MDA-deoxyguanosine adduct 3-beta-D-erythro-pentofuranosylpyrimido[1,2-alpha]purin-10(3H)-one (M(1)G-R) were prepared and characterized. Several MDA-modified nucleosides and deoxynucleosides and structural analogs were synthesized and characterized and were compared as competitive inhibitors in enzymelinked immunosorbent assays (ELISAs). Less than 5 fmol of M(1)G in MDA-modified DNA was detected in a direct ELISA, and antibody binding to the modified DNA was competitively inhibited by free M(1)G-dR. DNA from Salmonella typhimurium treated with concentrations of MDA that induce reversion to histidine prototrophy was enzymatically digested, and M(1)G-dR was quantitated by competitive ELISA. Over a range of MDA concentrations from 10 to 40 mM, the level of M(1)G residues in bacterial DNA increased from 0.2 to 2.5/10(6) base pairs.
  • An Improved <sup>32</sup>P-Postlabeling/High-Performance Liquid Chromatography Method for the Analysis of the Malondialdehye-Derived 1,<i>N</i><sup>2</sup>-Propanodeoxyguanosine DNA Adduct in Animal and Human Tissues
    作者:Ping Yi、Xin Sun、Daniel R. Doerge、Peter P. Fu
    DOI:10.1021/tx9800497
    日期:1998.9.1
    Malondialdehyde (MDA) is a major lipid peroxidation product that is mutagenic and tumorigenic. The MDA-modified DNA adduct, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)pyr [1,2-alpha]purin-10(3H)-one (M(1)G), has been detected in human tissues and may be a marker of human cancer risk. In this paper, we describe an improved P-32-postlabeling/HPLC method for sensitive detection and quantitation of this MDA-modified 2'-deoxyribonucleotide adduct. Specific improvements include (i) unequivocal structural identification of the postlabeling products, both the 3',5'-bisphosphate of M(1)G (MDA-3',5'-dGDP) and the 5'-monophosphate of M1G (MDA-5'-dGMP); (ii) efficient separation of the P-32-postlabeling products by HPLC; and (iii) the incorporation of a synthetically prepared MDA-modified DNA (or the 3'-monophosphate of M(1)G) with a known modification level as an internal standard. This improved quantitative methodology provides high intra- and inter-assay reproducibility and has been applied to the analysis of this adduct in rodent and human samples.
  • Kinetic and Thermodynamic Analysis of the Hydrolytic Ring-Opening of the Malondialdehyde−Deoxyguanosine Adduct, 3-(2‘-Deoxy-β-<scp>d</scp>-<i>e</i><i>rythro</i>-pentofuranosyl)- pyrimido[1,2-α]purin-10(3<i>H</i>)-one
    作者:James N. Riggins、J. Scott Daniels、Carol A. Rouzer、Lawrence J. Marnett
    DOI:10.1021/ja040009r
    日期:2004.7.1
    3-(2'- Deoxy-beta-D-erythro-pentofuranosyl) pyrimido[1,2-alpha]purin-10(3H)-one (M(1)dG) is the major reaction product of deoxyguanosine with malondialdehyde or base propenals. M(1)dG undergoes hydrolytic ring-opening to N-2-oxopropenyl-deoxyguanosine (N(2)OPdG) under basic conditions. We report that ring-opening of M(1)dG as a nucleoside or in oligonucleotides is a reversible second-order reaction with hydroxide ion. NMR and UV analysis revealed N(2)OPdG(-) to be the only product of M(1)dG ring-opening in basic solution. The rate constant for reaction of M1dG with hydroxide is 3.8 M-1 s(-1), and the equilibrium constant is calculated to be 2.1 +/- 0.3 x 10(4) M-1 at 25 degreesC. Equilibrium constants determined by spectroscopic analysis of the reaction end-point or by thermodynamic analysis of rate constants determined over a range of temperatures yielded a value 2.5 +/- 0.2 x 10(4) M-1. Kinetic analysis of ring-opening of M1dG in oligonucleotides indicated the rate constant for ring-opening is decreased 10-fold compared to that in the nucleoside. Flanking purines or pyrimidines did not significantly alter the rate constants for ring-opening, but purines flanking M1dG enhanced the rate constant for the reverse reaction. A mechanism is proposed for ring-opening of M(1)dG under basic conditions and a role is proposed for duplex DNA in accelerating the rate of ring-opening of M(1)dG at neutral pH.
查看更多

同类化合物

顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 阿巴卡韦羧酸盐 阿巴卡韦相关物质D 阿巴卡韦杂质F 阿巴卡韦杂质 阿巴卡韦中间体A5 阿巴卡韦5’-磷酸酯 阿巴卡韦,拉米夫定混合物 阿巴卡韦 芒霉素 艾夫他滨 腺苷基(3'-5')胞苷基(3'-5')胞苷游离酸 脱氧假尿苷 胸苷酰-(5'-3')-胸苷酰-(5'-3')-胸苷酰-(5'-3')-5'-胸苷酸 胰腺癌RX-3117 硫酸阿巴卡韦 甲基磷羧酸氢[(2S,5R)-5-(4-氨基-2-羰基嘧啶-1(2H)-基)-2,5-二氢呋喃-2-基]甲酯 瓶型酵母D 瓶型酵母A 环戊烯基尿嘧啶 水杨酸拉米呋啶 氟达拉滨EP杂质H 曲沙他滨 拉米夫定相关化合物(Α-TROXACITABINE) 拉米夫定杂质Ⅲ1-[(2R,5S)-2-羟甲基-1,3-氧硫杂环戊-5-基]-嘧啶-2,4(1H,3H)-酮 拉米夫定杂质1 拉米夫定S-氧化物(异构体混合物) 拉米夫定 拉米夫定 拉夫米定EP杂质J 拉夫米定EP杂质H 扎西他宾 恩替卡韦相关物质A 恩替卡韦一水合物 恩曲他滨杂质16 恩曲他滨S-氧化物 恩曲他滨 恩曲他滨 怀俄苷三乙酸酯 怀俄苷 己二酸,聚合1,2-丁二醇 外消旋拉米夫定酸 吡唑霉素 司他夫定 反式-阿巴卡韦盐酸盐 卡波啶 卡巴韦